The clinical anti-aging effects of topical kinetin and niacinamide in Asians: A randomized, double-blind, placebo-controlled, split-face comparative trial

Journal of Cosmetic Dermatology

Volumn 6, Issue 4, 2007, Pages 243-249

  Chiu, P Cin Chi ^a   Chan, Chih Chieh ^a   Lin, Hui Min ^a   Chiu, Hsien Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cosmeceuticals; Kinetin (N6 furfuryladenine); Niacinamide

Indexed keywords

KINETIN; NICOTINAMIDE; PLACEBO;

ADULT; AGING; ARTICLE; ASIA; BIOMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA EDEMA; CUTANEOUS PARAMETERS; ERYTHEMA; HUMAN; HUMAN EXPERIMENT; HYDRATION; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SKIN CARE; WRINKLE;

ADMINISTRATION, CUTANEOUS; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KINETIN; MALE; MIDDLE AGED; NIACINAMIDE; SEVERITY OF ILLNESS INDEX; SKIN AGING; TAIWAN; TREATMENT OUTCOME;

EID: 36749091197     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2007.00342.x     Document Type: Article

References (38)

1. Rabe JH, Mamelak AJ, McElgunn PJ, Morison WL. Photoaging: Mechanisms and repair. J Am Acad Dermatol 2006; 55: 1-19.
2. Miller CO, Skoog F, von Saltza MH, Strong FM. Kinetin, a cell division factor from deoxyribonucleic acid. J Am Chem Soc 1955; 77: 1392.
3. Amasino R. 1955. kinetin arrives: The 50th anniversary of a new plant hormone. Plant Physiol 2005; 138: 1177-84.
4. Barciszewski J, Siboska GE, Pedersen BO, Clark BFC, Rattan SIS. Evidence for the presence of kinetin in DNA and cell extracts. FEBS Lett 1996; 393: 197-200.
5. Barciszewski J, Mielcarek M, Stobiecki M, Siboska G, Clark BF. Identification of 6-furfuryladenine (kinetin) in human urine. Biochem Biophys Res Commun 2000; 279: 69-73.
6. Barciszewski J, Siboska GE, Pedersen BO, Clark BF, Rattan SI. Furfural, a precursor of the cytokinin hormone kinetin, and base propenals are formed by hydroxyl radical damage of DNA. Biochem Biophys Res Commun 1997; 238: 317-9.
7. Rattan SIS, Clark BFC. Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem Biophys Res Commun 1994; 20: 665-72.
8. Sharma SP, Kaur P, Rattan SIS. Plant growth hormone kinetin delays aging, prolongs the life span and slows down development of the fruifly Zapronius paravittiger. Biochem Biophys Res Commun 1995; 216: 1067-71.
9. Sharma SP, Kaur J, Rattan SIS. Increased longevity of kinetin-fed Zapronius fruitflies is accompanied by their reduced fecundity and enhanced catalase activity. Biochem Mol Biol Int 1997; 41: 869-75.
10. Olsen A, Siboska GE, Clark BF, Rattan SIS. N(6)-furfuryladenine, kinetin, protects against Fenton reaction-mediated oxidative damage to DNA. Biochem Biophys Res Commun 1999; 265: 499-502.
11. Verbeke P, Siboska GE, Clark BF, Rattan SI. Kinetin inhibits protein oxidation and glycoxidation in vitro. Biochem Biophys Res Commun 2000; 276: 1265-70.
12. Hsiao G, Shen MY, Lin KH et al. Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo. Eur J Pharmacol 2003; 465: 281-7.
13. Sheu JR, Hsiao G, Shen MY et al. Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation. Platelets 2003; 14: 189-96.
14. Lee JH, Chung KY, Bang D, Lee KH. Searching for aging-related proteins in human dermal microvascular endothelial cells treated with anti-aging agents. Proteomics 2006; 6: 1351-61.
15. Ishii Y, Sakai S, Honma Y. Cytokinin-induced differentiation of human myeloid leukemia HL-60 cells is associated with the formation of nucleotides, but not with incorporation into DNA or RNA. Biochim Biophys Acta 2003; 1643: 11-24.
16. Berge U, Kristensen P, Rattan SI. Kinetin-induced differentiation of normal human keratinocytes undergoing aging in vitro. Ann N Y Acad Sci 2006; 1067: 332-6.
17. Kimura T, Doi K. Depigmentation and rejuvenation effects of kinetin on the aged skin of hairless descendants of Mexican hairless dogs. Rejuvenation Res 2004; 7: 32-9.
18. McCullough JL, Weinstein GD. Clinical study of safety and efficacy of using topical kinetin 0.1%; (Kinerase) to treat photodamaged skin. Cosmet Derm 2002; 15: 29-32.
19. Gensler HL. Prevention of photoimmunesuppression and photocarcinogenesis by topical niacinamide. Nutr Cancer 1997; 29: 157-62.
20. YuJ-M, Liu Y, Xie N et al. Effects of niacinamide on levels of dermis hydroxyproline in photoaging skin. Huanjing Yu Jiankang Zazhi 2002; 19: 102-4.
21. Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK. Topical niacinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol 1995; 34: 434-7.
22. Griffiths CEM. Niacinamide 4% gel for the treatment of inflammatory acne vulgaris. J Dermatol Treat 1995; 6: S8-10.
23. Berk MA, Lorincz AL. The treatment of bullous pemphigoid with tetracycline and niacinamide: A preliminary report. Arch Dermatol 1986; 122: 670-4.
24. Hakozaki T, Minwealla L, Zhuang J et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147: 22-33.
25. Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Niacinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol 2000; 143: 524-31.
26. Bissett DL, Miyamoto K, Sun P et al. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci 2004; 26: 231-8.
27. Bissett DL, Oblong JE, Berge CA. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg 2005; 31: 860-5.
28. Soma Y, Kashima M, Imaizumi A, Takahama H, Kawakami T, Mizoguchi M. Moisturizing effects of topical niacinamide on atopic dry skin. Int J Dermatol 2005; 44: 197-202.
29. Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis 2005; 76: 135-41.
30. Draelos ZD, Matsubara A, Smiles K. The effect of 2% niacinamide on facial sebum production. J Cosmet Laser Ther 2006; 8: 96-101.
31. Barciszewski J, Massino F, Clark BFC. Kinetin - A multiactive molecule. Int J Biol Macromol 2007; 40: 182-92.
32. Weinstein GD, McCullough JL, Ali NN et al. A double blind vehicle controlled study of kinetin lotions for improving the appearance of aging photodamaged facial skin with 24 weeks of twice daily application. In photoaging: Latest advances in understanding, treatment and prevention. (Presentation-IBC conference, Short Hills, August 1997).
33. Dickens MS, Edison NJ, Levy SB et al. Kinetin-containing lotion compared with retinol-containing lotion: Comparable improvements in the signs of photoaging. (Poster -The annual meeting of American Academy of Dermatology, New Orleans, 2002).
34. Matts PJ, Oblong JE, Bissett DL. A review of the range of effects of niacinamide in human skin. Int Fed Soc Cosmet Chem Mag 2002; 5: 285-9.
35. Gehring W. Nicotinic acid/niacinamide and the skin. J Cosmet Dermatol 2004; 3: 88-93.
36. McDaniel DH, Neudecker BA, Dinardo JC, Lewis JA 2nd, Maibach HI. Idebenone: A new antioxidant -Part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants. J Cosmet Dermatol 2005; 4: 10-7.
37. Piérard-Franchimont C, Piérard GE, Kligman A. Seasonal modulation of the sebum excretion. Dermatologica 1990; 181: 21-2.
38. Roh M, Han M, Kim D et al. Sebum output as a factor contributing to the size of facial pores. Br J Dermatol 2006; 155: 890-4.